Sunmax Biotechnology Co., Ltd. total revenue, net income and dynamics of changes in Taiwan new dollar today
Sunmax Biotechnology Co., Ltd. current income and income for the latest reporting periods. The dynamics of Sunmax Biotechnology Co., Ltd. net revenue fell by -28 786 000 $ compared to the previous report. The dynamics of net income of Sunmax Biotechnology Co., Ltd. has changed by -38 959 000 $ in recent years. The value of "net income" Sunmax Biotechnology Co., Ltd. on the graph is displayed in blue. Sunmax Biotechnology Co., Ltd. total revenue on the graph is shown in yellow. The value of all Sunmax Biotechnology Co., Ltd. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Sunmax Biotechnology Co., Ltd. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Sunmax Biotechnology Co., Ltd. for today is 31/03/2021. Gross profit Sunmax Biotechnology Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sunmax Biotechnology Co., Ltd. is 243 317 000 $
Cost of revenue Sunmax Biotechnology Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Sunmax Biotechnology Co., Ltd. is 23 730 000 $ Total revenue Sunmax Biotechnology Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sunmax Biotechnology Co., Ltd. is 267 047 000 $ Operating income Sunmax Biotechnology Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sunmax Biotechnology Co., Ltd. is 90 425 000 $
Net income Sunmax Biotechnology Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sunmax Biotechnology Co., Ltd. is 62 935 000 $ Current assets Sunmax Biotechnology Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sunmax Biotechnology Co., Ltd. is 977 706 000 $ Total assets Sunmax Biotechnology Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Sunmax Biotechnology Co., Ltd. is 1 422 562 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
7 937 000 540 $
8 181 813 640 $
4 093 124 980 $
5 676 467 160 $
5 464 861 220 $
4 490 208 240 $
2 677 058 160 $
2 722 269 480 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
774 072 600 $
1 468 258 820 $
2 202 535 020 $
721 228 200 $
721 293 440 $
568 305 640 $
438 053 980 $
497 128 800 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
8 711 073 140 $
9 650 072 460 $
6 295 660 000 $
6 397 695 360 $
6 186 154 660 $
5 058 513 880 $
3 115 112 140 $
3 219 398 280 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 949 663 500 $
4 014 608 640 $
693 305 480 $
2 983 327 340 $
2 713 005 400 $
1 672 101 200 $
593 749 240 $
885 143 700 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
2 052 939 700 $
3 323 782 280 $
616 615 860 $
1 989 102 360 $
1 918 088 620 $
1 082 364 220 $
739 560 640 $
975 142 280 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
143 952 060 $
139 026 440 $
66 446 940 $
201 819 940 $
187 760 720 $
182 378 420 $
231 406 280 $
201 787 320 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 761 409 640 $
5 635 463 820 $
5 602 354 520 $
3 414 368 020 $
3 473 149 260 $
3 386 412 680 $
2 521 362 900 $
2 334 254 580 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
31 892 769 720 $
31 495 523 360 $
29 714 112 540 $
28 377 410 180 $
23 616 260 220 $
24 002 611 500 $
20 732 880 560 $
18 909 683 520 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
46 403 972 440 $
44 497 170 340 $
40 267 791 620 $
38 198 117 860 $
32 576 517 540 $
33 010 396 160 $
30 704 781 940 $
24 722 502 280 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
27 750 975 700 $
25 397 279 600 $
23 128 330 260 $
21 517 554 660 $
14 966 023 380 $
16 593 467 800 $
14 436 013 620 $
10 253 575 080 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
4 984 923 160 $
7 078 213 800 $
2 523 352 720 $
2 331 677 600 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
9 987 754 700 $
12 210 187 920 $
8 647 986 060 $
3 584 416 080 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
30.66 %
36.99 %
28.16 %
14.50 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
30 994 480 160 $
28 993 895 560 $
23 759 135 820 $
23 037 157 360 $
22 588 762 840 $
20 800 208 240 $
22 056 795 880 $
21 138 086 200 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
1 565 303 320 $
3 010 891 240 $
1 404 812 920 $
1 479 806 300 $
Last revenue report of Sunmax Biotechnology Co., Ltd. was 31/03/2021. According to last financial report total revenue in Sunmax Biotechnology Co., Ltd. was 8 711 073 140 Taiwan new dollar and changed by +179.64% since last year. Net income in Sunmax Biotechnology Co., Ltd. was 2 052 939 700 $ in last quartal, net income changes to +177.59%.
Current cash Sunmax Biotechnology Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Sunmax Biotechnology Co., Ltd. is 850 735 000 $
